Plasminogen Activator Inhibitor-2 and Alpha-Fetoprotein in Various Liver Disease States

• References

• 1 Lecander I, Åstedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986; 62: 221-228
• 2 Åstedt B, Lecander I, Ny T. The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1987; 1: 203-208
• 3 Åstedt B, Hagerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemostas 1986; 56: 63-65
• 4 Kruithof EKO, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator 2 in various disease states. Thromb Haemostas 1988; 59: 07-12
• 5 Tran-Thang C, Fasel-Felley J, Pralong G. et al Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism and infectious hepatitis. Thromb Haemostas 1989; 62: 651-653
• 6 Bates SE, Longo DL. Use of serum tumor markers in cancer diagnosis and management. Semin Oncol 1987; 14: 102-138
• 7 Waldmann TA, McIntire KR. The use of radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 1974; 34: 1510-1515
• 8 Wepsic HT. Alpha-fetoprotein: Its quantitation and relationship to neoplastic disease. Alpha-fetoprotein. Laboratory Procedures and Clinical Applications Kirkpatrick AM, Nakamura RM. Masson, New York: 1981: 115-29